Biotechblog – Page 903 – Biotechnology business, policy, and more!

Branding Biotech – Communicating the Brand’s Point of Differentiation

This is a guest post from Brannon Cashion, President of Addison Whitney Health. Do you have a response to Brannin’s post? […]

Following two posts on Brexit and British biotechnology, I would like to provide a perspective that turns everything on its

In the wake of my recent post on the potential impact of Brexit on British Biotechnology, I am fortunate to

I have a tool that can be used to measure the impact of Brexit on biotechnology in the United Kingdom.

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s

DrugPatentWatch offers PDF copies of the FDA Orange Book dating back to 1980. The Food and Administration (FDA) Orange Book, or Approved

On Thursday June 9th from 10:30 to 11:30pm in Room 124 North Mike May and I will be going over the

My book signing sold out, but do not despair — you can still get a signed copy. Signed copies of Building

I will be signing my textbook Building Biotechnology, and other books, in the BIO bookstore on Wednesday June 8th from 12:30 pm

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s